"Phenylpropanolamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sympathomimetic that acts mainly by causing release of NOREPINEPHRINE but also has direct agonist activity at some adrenergic receptors. It is most commonly used as a nasal vasoconstrictor and an appetite depressant.
| Descriptor ID |
D010665
|
| MeSH Number(s) |
D02.033.100.624.706 D02.033.755.624.706 D02.092.063.624.706
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phenylpropanolamine".
Below are MeSH descriptors whose meaning is more specific than "Phenylpropanolamine".
This graph shows the total number of publications written about "Phenylpropanolamine" by people in this website by year, and whether "Phenylpropanolamine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 1 | 1 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 4 | 0 | 4 |
| 2011 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phenylpropanolamine" by people in Profiles.
-
Reliability and responsiveness of the Urgency Severity and Life Impact Questionnaire (USIQ). Int Urogynecol J. 2012 Feb; 23(2):193-6.
-
Correlates and predictors of patient satisfaction with drug therapy and combined drug therapy and behavioral training for urgency urinary incontinence in women. Int Urogynecol J. 2011 Mar; 22(3):327-34.
-
Tolterodine causes measurable restoration of urethral sensation in women with urge urinary incontinence. Neurourol Urodyn. 2010 Apr; 29(4):555-7.
-
Efficacy and safety of tolterodine extended release and dutasteride in male overactive bladder patients with prostates >30 grams. Urology. 2010 May; 75(5):1144-8.
-
The effects of drug and behavior therapy on urgency and voiding frequency. Int Urogynecol J. 2010 Jun; 21(6):711-9.
-
Tolterodine extended-release for overactive bladder. Expert Opin Pharmacother. 2009 Sep; 10(13):2181-94.
-
Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct. 2009 Jul; 20(7):827-35.
-
Behavioral therapy to enable women with urge incontinence to discontinue drug treatment: a randomized trial. Ann Intern Med. 2008 Aug 05; 149(3):161-9.
-
Safety and tolerability of extended-release oxybutynin once daily in urinary incontinence: combined results from two phase 4 controlled clinical trials. Int Urol Nephrol. 2007; 39(4):1069-77.
-
Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol. 2005 Jun; 192(6):1849-54; discussion 1854-5.